Publications show all

Gemin X Biotechnologies has published 2 articles.

Patents show all

36Applications31Issued

SEC Filings show all

D3

Private Funding Events

DateOfferedSoldType
2010-05-14$8,500,000$3,916,229Equity, Option to Acquire
2009-06-12$20,000,000$9,259,078Debt
2007-07-16UnknownUnknownOther (Paper Filing)

Key Executives

  • Peter R. Dolan
    Executive Officer, Director
  • Gordon C. Shore
    Executive Officer, Director
  • D. Michael Dixon
    Executive Officer
  • Jean Viallet
    Executive Officer
  • Robert G. McNeil
    Director
  • Timothy J. Barberich
    Director
  • Aaron Davidson
    Director
  • Robert Gorman
    Director
  • Andrew R. Jordan
    Director
  • Eric W. Roberts
    Director
  • Scott Morenstein
    Director